CTX leverages the capabilities and expertise of its Industry Partners with those of a number of Australia’s pre-eminent medical research Institutes and universities and is always in search of licensing partners and investors that share its mission.
CTX also engages in ground breaking research targeted at the treatment of various cancers, has successfully out-licensed multiple oncology programs and has established itself as a leader in epigenetics and immuno-oncology.
For more information, visit the Cancer Therapeutics website here